Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Mineralys Therapeutics, Inc. MLYS

Set alert

Price alert · MLYS

All alert types
15.55 USD -2.63 -14.47%

At close

15.59 +0.04 +0.26%

Pre-market · Nov 3, 5:29 AM ET

Bid
15.50 × 1
Ask
15.52 × 1
15.42 Day range 18.29
15.42 52-week range 47.65
YTD
-57.15%
1 year
-61.94%
Open
18.27
Prev close
18.18
Mkt cap
1.37B
Vol
4.59M
Avg vol
1.28M
EPS
-3.61
P/E
0.00
Div yield
0.00%
More statistics
Low
15.42
High
18.29
Forward P/E
-6.24
Beta
0.82
Short ratio
4.98
Inst. own
120.14%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
24.78
200-d avg
26.99
1y target
45.22

5D chart

Chart tools
Interval
1m5m15m30m

Signals (90)
NameTimeAgo
MACD: Sell SignalNov 2, 3:50 PM13 hours ago
RSI: OversoldNov 2, 3:50 PM13 hours ago
SMA: BearishNov 2, 3:25 PM14 hours ago
SMA: BullishNov 2, 2:45 PM14 hours ago
MACD: Buy SignalNov 2, 2:45 PM14 hours ago
RSI: OversoldNov 2, 1:50 PM15 hours ago
MACD: Sell SignalNov 2, 1:30 PM16 hours ago
RSI: OversoldNov 2, 1:30 PM16 hours ago
SMA: BearishNov 2, 1:25 PM16 hours ago
SMA: BearishNov 2, 1:00 PM16 hours ago
SMA: BullishNov 2, 12:40 PM16 hours ago
RSI: OversoldNov 2, 11:50 AM17 hours ago
RSI: OversoldNov 2, 11:40 AM17 hours ago
MACD: Buy SignalNov 2, 11:35 AM18 hours ago
SMA: BullishNov 2, 11:30 AM18 hours ago
RSI: OversoldNov 2, 9:55 AM19 hours ago
SMA: BearishNov 2, 9:40 AM19 hours ago
MACD: Sell SignalNov 2, 9:40 AM19 hours ago
RSI: OversoldNov 2, 9:40 AM19 hours ago
RSI: OversoldOct 30, 3:15 PM3 days ago

Newest 20 of 90.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 45.22 +190.8% upside
Target (low)
20.00
Target (mean)
45.22
Target (high)
56.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy9
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MLYS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.53938-0.60 – -0.39-0.52-3.7%00.0%8
Next quarter-0.58973-0.73 – -0.45-0.40-47.4%00.0%8
Current year-4.43-4.63 – -3.93-2.29-93.6%00.0%8
Next year-2.49-3.78 – -1.20-4.43+43.8%84.31M0.0%9

Upgrades and downgrades

The latest rating changes

MLYS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026UBSInitiated—Neutral
Oct 12, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 27, 2026TD CowenInitiated—Buy
Mar 13, 2026B of A SecuritiesMaintainedBuyBuy
Dec 19, 2025StifelMaintainedBuyBuy
Nov 12, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 11, 2025Wells FargoMaintainedOverweightOverweight
Oct 30, 2025HC Wainwright & Co.MaintainedBuyBuy
Sep 11, 2025Wells FargoMaintainedOverweightOverweight
Sep 9, 2025Goldman SachsMaintainedBuyBuy
Sep 8, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 3, 2025JefferiesMaintainedHoldHold
Aug 28, 2025B of A SecuritiesMaintainedBuyBuy
Aug 13, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jun 17, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jun 11, 2025JefferiesInitiated—Hold
May 13, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 2, 2025HC Wainwright & Co.MaintainedBuyBuy
Mar 10, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 24, 2025GuggenheimReiteratedBuyBuy
Feb 13, 2025Goldman SachsMaintainedBuyBuy
Feb 13, 2025HC Wainwright & Co.ReiteratedBuyBuy
Nov 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 10, 2024HC Wainwright & Co.Initiated—Buy
Apr 2, 2024Goldman SachsInitiated—Buy
Aug 8, 2023Credit SuisseMaintainedOutperformOutperform
May 16, 2023Credit SuisseReiteratedOutperformOutperform
Mar 16, 2023Credit SuisseMaintained—Outperform